Cardiovascular problems in successfully treated cancer patients is recognized as a major clinical problem. An increased number of cancer patients defeats the disease, but suffer from therapy induced cardiovascular complications later in life. Assessing the cardiovascular health of cancer patients prior, during and post treatment reduces these complications.

 

ACS Biomarker offers a biomarker panel* composed of gold standard cardiovascular proteins and novel RNA markers specifically developed for assessing the cardiovascular condition of cancer patients in clinical trials or retrospective oncology studies.

 

 

​

​

*for research use only